Longitudinal Assessment and Functional Outcomes in Patients with Hematologic Malignancies and Related Disorders
Conditions
Hematologic Malignancies
Trial Phase
Trial Purpose and Description
Trial Purpose
Participation Guidelines
- Age:
- 18 Years and older
- Gender:
- Both
Eligibility Criteria
- Sponsor:
- Yale University
- Dates:
- January 2009
- Last Updated:
- Study HIC#:
- 0811004415
Clinicaltrials.gov ID: Yale1196361
For more information about this trial, contact:
Investigator
Stephanie Halene, MD, PhD
Principal Investigator
